Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 1
2023 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for M. gabardi
Your search for M. Nabardi retrieved no results
Fibre-infused gel scaffolds guide cardiomyocyte alignment in 3D-printed ventricles.
Choi S, Lee KY, Kim SL, MacQueen LA, Chang H, Zimmerman JF, Jin Q, Peters MM, Ardoña HAM, Liu X, Heiler AC, Gabardi R, Richardson C, Pu WT, Bausch AR, Parker KK. Choi S, et al. Nat Mater. 2023 Aug;22(8):1039-1046. doi: 10.1038/s41563-023-01611-3. Epub 2023 Jul 27. Nat Mater. 2023. PMID: 37500957 Free PMC article.
CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
Mallat SG, Tanios BY, Itani HS, Lotfi T, McMullan C, Gabardi S, Akl EA, Azzi JR. Mallat SG, et al. Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1321-1336. doi: 10.2215/CJN.13221216. Epub 2017 Jun 2. Clin J Am Soc Nephrol. 2017. PMID: 28576905 Free PMC article.
There was no difference in graft loss in both comparisons. eGFR was higher in the mTOR inhibitor-based group in comparison 1 (mean difference =4.07 ml/min per 1.73 m(2); 95% confidence interval, 1.34 to 6.80) and similar to the calcineurin inhibitor-based group in comparis …
There was no difference in graft loss in both comparisons. eGFR was higher in the mTOR inhibitor-based group in comparison 1 (mean differenc …
Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy.
Pérez-Sáez MJ, Yu B, Uffing A, Murakami N, Borges TJ, Azzi J, El Haji S, Gabardi S, Riella LV. Pérez-Sáez MJ, et al. Clin Kidney J. 2018 Dec 1;12(4):586-591. doi: 10.1093/ckj/sfy115. eCollection 2019 Aug. Clin Kidney J. 2018. PMID: 31384452 Free PMC article.
We observed an increase in eGFR in the whole cohort from 35.4 to 41 mL/min/1.73 m(2) at 3 months (P = 0.032) and 43.7 at 12 months (P = 0.013). Nine patients experienced acute rejection post-conversion, with one graft loss observed beyond the first year after conversion. P …
We observed an increase in eGFR in the whole cohort from 35.4 to 41 mL/min/1.73 m(2) at 3 months (P = 0.032) and 43.7 at 12 months (P …